tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
Holding CRDF?
Track your performance easily

Cardiff Oncology (CRDF) Technical Analysis

1,527 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cardiff Oncology, Inc.’s (CRDF) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Cardiff Oncology, Inc. is a Buy.
Cardiff Oncology, Inc.’s (CRDF) 20-Day exponential moving average is 2.92, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.5, making it a Sell.
Cardiff Oncology, Inc.’s (CRDF) 50-Day exponential moving average is 2.85, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.5, making it a Sell.

Cardiff Oncology (CRDF) Pivot Points

Nov 22, 2024, 05:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.32
2.41
2.47
2.56
2.62
2.71
2.77
Fibonacci
2.41
2.47
2.51
2.56
2.62
2.66
2.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cardiff Oncology (CRDF) Moving Averages

Nov 22, 2024, 05:37 AM
Period
Simple
Exponential
MA5
2.56Sell
2.62Sell
MA10
2.83Sell
2.79Sell
MA20
3.10Sell
2.92Sell
MA50
2.84Sell
2.85Sell
MA100
2.57Sell
2.76Sell
MA200
3.10Sell
2.79Sell
Cardiff Oncology, Inc.’s (CRDF) 10-Day exponential moving average is 2.79, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.5, making it a Sell.
Cardiff Oncology, Inc.’s (CRDF) 100-Day exponential moving average is 2.76, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.5, making it a Sell.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.5 and Cardiff Oncology, Inc.’s (CRDF) 50-day simple moving average is 2.84, creating a Sell signal.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.5 and Cardiff Oncology, Inc.’s (CRDF) 100-day simple moving average is 2.57, creating a Sell signal.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.5 and Cardiff Oncology, Inc.’s (CRDF) 200-day simple moving average is 3.10, creating a Sell signal.

Cardiff Oncology (CRDF) Technical Indicators

Nov 22, 2024, 05:37 AM
Name
Value
Implied Action
RSI (14)
40.07
Neutral
STOCH (9,6)
3.25
Buy
STOCHRSI (14)
2.85
Buy
MACD (12,26)
-0.08
Buy
ADX (14)
28.15
Neutral
Williams %R
-98.17
Buy
CCI (14)
-117.33
Buy
ATR (14)
0.31
-
Ultimate Oscillator
31.86
Neutral
ROC
-21.88
Sell
Cardiff Oncology, Inc.’s (CRDF) Relative Strength Index (RSI) is 40.07, creating a Neutral signal.
Cardiff Oncology, Inc.’s (CRDF) Trend Strength Indicator (ADX) is 28.15, creating a Neutral signal.
Cardiff Oncology, Inc.’s (CRDF) Commodity Channel Index (CCI) is -117.33, creating a Buy signal.
Cardiff Oncology, Inc.’s (CRDF) Price Rate of Change (ROC) is -21.88, creating a Sell signal.

FAQ

Is CRDF a Buy, Hold, or Sell?
Based on CRDF’s technical indicators, CRDF is a Sell.
    What is CRDF’s RSI (14)?
    CRDF’s RSI (14) is 40.07, which suggests CRDF is a Neutral.
      What is CRDF’s MACD?
      CRDF’s MACD is -0.08, which suggests CRDF is a Buy.
        What is CRDF’s 5-day moving average?
        CRDF’s 5-day moving average is 2.56, which suggests CRDF is a Sell.
          What is CRDF’s 20-day moving average?
          CRDF 20-day moving average is 3.10, which suggests CRDF is a Sell.
            What is CRDF’s 50-day moving average?
            CRDF’s 50-day moving average is 2.84, which suggests CRDF is a Sell.
              What is CRDF’s 200-day moving average?
              CRDF’s 200-day moving average is 3.10, which suggests CRDF is a Sell.
                What is CRDF’s Williams % R (14)?
                CRDF’s Williams % R (14) is -98.17, which suggests CRDF is a Buy.
                  What is CRDF’s CCI (14)?
                  CRDF’s CCI (14) is -117.33, which suggests CRDF is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis